Castle Biosciences Cash Flow Statement (2018-2026) | CSTL

Cash Flow Statement Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-11.79M-13.38M-24.62M-1.65M-20.25M-20.62M-29.20M-18.78M-6.91M-2.58M-2.53M8.92M2.27M9.59M-25.85M4.56M-0.50M-2.33M-14.52M-2.06M
Depreciation and Depletion (Quarter)
0.40M0.44M0.50M0.53M0.62M0.63M0.67M0.79M0.90M0.95M1.09M1.10M1.27M1.43M1.44M1.45M1.54M1.50M1.70M1.82M
Share-based Compensation (Quarter)
0.43M0.35M0.06M0.03M5.82M-4.22M0.31M0.17M0.01M1.05M12.68M-12.68M38.88M-38.27M11.18M-6.49M9.78M11.59M
Deferred Taxes (Quarter)
-8.74M0.12M-1.96M-0.04M0.01M-0.24M-1.54M5.25M-2.31M-0.77M-4.67M0.12M-0.91M-0.01M-0.00M
Gains from Investment Securities (Quarter)
2.56M-20.40M-0.15M-0.30M
Cash from Operations (Quarter)
-6.13M-2.78M-21.43M-9.00M-5.22M-6.00M-25.44M-3.79M5.01M18.59M-6.83M24.00M23.34M24.36M-6.04M20.82M22.63M26.93M-22.13M15.20M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.18M1.18M1.23M1.05M1.57M1.64M1.70M1.72M1.65M1.61M1.44M1.17M0.91M0.71M0.45M0.39M
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)
1.09M1.45M2.15M2.63M2.92M2.84M2.89M3.04M3.17M3.22M3.34M3.35M3.54M5.77M29.76M3.41M3.82M3.78M3.93M4.07M
Change in Working Capital
Change in Receivables (Quarter)
0.81M-1.46M2.73M2.90M0.05M0.54M4.38M3.60M5.80M1.15M4.26M3.36M4.25M0.77M5.22M-3.91M-1.91M-6.27M-1.07M5.82M
Change in Inventory (Quarter)
0.25M-0.35M0.33M0.74M0.44M0.18M0.54M1.60M-0.35M2.17M-0.30M0.37M-1.44M1.56M-1.29M1.52M0.31M1.60M0.21M0.12M
Change in Account Payables (Quarter)
1.36M-0.85M0.19M0.12M1.85M-1.57M3.90M-0.82M-0.38M3.01M-0.42M-1.23M-2.15M-0.57M0.61M1.07M1.41M-0.02M3.19M-2.31M
Change in Accured Expenses (Quarter)
1.14M-0.90M-6.92M5.90M0.16M9.35M-11.56M13.61M-0.67M0.76M0.07M-0.01M-1.34M1.59M-14.70M15.17M-1.27M1.66M2.75M7.78M
Other Working Capital Changes (Quarter)
0.64M-1.35M-0.04M-0.46M-0.03M1.76M0.65M-0.81M0.61M-0.02M0.10M0.19M-0.26M-0.30M3.36M-3.35M4.52M-4.17M6.67M0.88M
Investing Activities
Capital Expenditures (Quarter)
0.19M-0.16M0.03M1.77M-0.68M4.50M3.34M4.04M2.46M-8.60M0.70M13.68M-12.81M0.66M4.74M2.08M22.02M-17.50M4.10M8.65M
Sales of Property, Plant and Equipment (Quarter)
0.00M0.00M0.01M0.00M0.19M0.01M0.00M0.00M0.00M0.01M0.00M0.00M0.01M0.01M0.01M0.02M0.01M0.01M0.01M
Acquisitions (Quarter)
0.30M
Change in Acquisitions & Divestments (Quarter)
50.00M45.00M43.00M48.50M50.20M36.25M36.80M-123.25M80.30M54.90M-133.67M2.68M41.00M
Cash from Investing Activities (Quarter)
-0.92M-30.89M-0.40M-27.51M-134.15M-4.48M16.58M-15.39M-9.71M-7.67M-19.70M-21.42M-14.79M5.77M-22.43M-28.38M-18.39M8.83M-25.80M-15.96M
Financing Activities
Other financing activities (Quarter)
-0.58M0.55M0.90M0.61M0.30M0.68M0.10M1.59M0.34M0.68M1.09M-1.02M2.26M0.65M0.02M0.02M1.67M0.50M1.27M0.84M
Cash from Financing Activities (Quarter)
1.89M0.13M1.22M0.66M0.39M-0.75M0.73M0.23M0.04M-3.30M10.64M0.04M0.84M-5.38M-1.55M0.10M-0.92M-4.59M-5.03M-0.89M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
Additional items
Change in Cash (Quarter)
-5.16M-33.54M-20.62M-35.85M-138.99M-11.23M-8.13M-18.95M-4.65M7.62M-15.89M2.62M9.39M24.75M-30.02M-7.46M3.32M31.17M-52.97M-1.65M
Free Cash Flow (Quarter)
-6.32M-2.62M-21.46M-10.78M-4.55M-10.50M-28.78M-7.82M2.56M27.19M-7.53M10.32M36.15M23.70M-10.78M18.74M0.62M44.43M-26.23M6.55M
Net Cash Flow (Quarter)
-5.16M-33.54M-20.62M-35.85M-138.99M-11.23M-8.13M-18.95M-4.65M7.62M-15.89M2.62M9.39M24.75M-30.02M-7.46M3.32M31.17M-52.97M-1.65M